Metastasis Associated 1 (MTA1) (Intermediate Domain) Peptid
MTA1
Reaktivität: Human
Wirt: Synthetic
BP, BI
-
- Target Alle MTA1 Produkte
- MTA1 (Metastasis Associated 1 (MTA1))
- Protein Region
- Intermediate Domain
- Spezies
- Human
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), BioImaging (BI)
- Produktmerkmale
- MTA1 peptide corresponds to 10 amino acids near the intermediate domain of MTA1.
-
Metastasis Associated 1 (MTA1) peptide
MTA1 Reaktivität: Human Wirt: Synthetic BP, Imm
-
- Applikationshinweise
- MTA1 Peptide is used for blocking the activity of MTA1 antibody . The MTA1 antibody ships at 0.5 mg/mL and the MTA1 Peptide ships as a 100 μg pellet. When peptide is reconstituted in 200 μLwater, the concentration will be 0.5 mg/mL, identical to that of the antibody. The best starting ratio would be 1:1 (which means molar excess of peptide relative to antibody when identical volumes are mixed). Mix equal volume of peptide and antibody at the required dilution and leave at ambient temperature for 20 minutes. Then incubate and develop in parallel two blots: one with the antibody and one with the antibody which has been pre-absorbed with the provided peptide.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- MTA1 peptide is supplied as 100 µg of dried peptide. When the peptide is reconstituted in 200 µL water, the concentration will be 0.5 mg/mL.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C. When reconstituted minimize freezing and thawing.
-
-
Sie sind hier:
